Elevated level of nerve growth factor in the bladder pain syndrome/interstitial cystitis: a meta-analysis

SpringerPlus

Volumn 5, Issue 1, 2016, Pages

  Chen, Wei ^a   Ye, Da Yong ^a   Han, Deng Jun ^a   Fu, Guang Qing ^a   Zeng, Xiang ^a   Lin, Wei ^a   Liang, Yong ^a  

^a Zigong No4 People s Hospital   (China)

Author keywords

Bladder pain syndrome; Interstitial cystitis; Meta analysis; Nerve growth factor

Indexed keywords

EID: 84978370506     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/s40064-016-2719-y     Document Type: Article

References (18)

1. Baykara M, Erdogru T, Gulkesen KH et al (2003) Does interstitial cystitis urine include possible factors effecting the nociceptive system of the spinal cord? [J]. Urol Int 71(1):66–72
2. Bosch PC, Bosch DC (2014) Treating interstitial cystitis/bladder pain syndrome as a chronic disease [J]. Rev Urol 16(2):83–87
3. Boudes M, Uvin P, Kerselaers S et al (2011) Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice [J]. Neurourol Urodyn 30(8):1659–1665
4. Chung SD, Liu HT, Lin H et al (2011) Elevation of serum c-reactive protein in patients with OAB and IC/BPS implies chronic inflammation in the urinary bladder [J]. Neurourol Urodyn 30(3):417–420
5. Diniz S, Dinis P, Cruz F et al (2013) Bladder pain syndrome/interstitial cystitis: present and future treatment perspectives [J]. Minerva Urol Nefrol 65(4):263–276
6. Jiang YH, Peng CH, Liu HT et al (2013) Increased pro-inflammatory cytokines, C-reactive protein and nerve growth factor expressions in serum of patients with interstitial cystitis/bladder pain syndrome [J]. PLoS ONE 8(10):e76779
7. Jiang YH, Liu HT, Kuo HC (2014) Decrease of urinary nerve growth factor but not brain-derived neurotrophic factor in patients with interstitial cystitis/bladder pain syndrome treated with hyaluronic acid [J]. PLoS ONE 9(3):e91609
8. Liu HT, Kuo HC (2007) Intravesical botulinum toxin A injections plus hydrodistension can reduce nerve growth factor production and control bladder pain in interstitial cystitis [J]. Urology 70(3):463–468
9. Liu HT, Kuo HC (2012) Increased urine and serum nerve growth factor levels in interstitial cystitis suggest chronic inflammation is involved in the pathogenesis of disease [J]. PLoS ONE 7(9):e44687
10. Liu HT, Tyagi P, Chancellor MB et al (2009) Urinary nerve growth factor level is increased in patients with interstitial cystitis/bladder pain syndrome and decreased in responders to treatment [J]. BJU Int 104(10):1476–1481
11. Liu HT, Chen CY, Kuo HC (2010) Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders [J]. J Formos Med Assoc 109(12):862–878
12. Liu BL, Yang F, Zhan HL et al (2014) Increased severity of inflammation correlates with elevated expression of TRPV1 nerve fibers and nerve growth factor on interstitial cystitis/bladder pain syndrome [J]. Urol Int 92(2):202–208
13. Ochodnicky P, Cruz CD, Yoshimura N et al (2011) Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target [J]. Neurourol Urodyn 30(7):1227–1241
14. Rubio-Diaz DE, Pozza ME, Dimitrakov J et al (2009) A candidate serum biomarker for bladder pain syndrome/interstitial cystitis [J]. Analyst 134(6):1133–1137
15. Seth JH, Sahai A, Khan MS et al (2013) Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? [J]. BJU Int 111(3):372–380
16. Tyagi P, Killinger K, Tyagi V et al (2012) Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis [J]. J Urol 187(6):2243–2248
17. Vandenbroucke JP (2009) STREGA, STROBE, STARD, SQUIRE, MOOSE, PRISMA, GNOSIS, TREND, ORION, COREQ, QUOROM, REMARK… and CONSORT: for whom does the guideline toll? [J]. J Clin Epidemiol 62(6):594–596
18. Wein AJ (2014) Re: nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)? [J]. J Urol 192(4):1163